Developing the Latest Technology for Nanoparticle Synthesis
12-18 June 2019, Bangkok, Thailand
We develop technologies that make synthesis of nanoparticles more effective and efficient. Effectiveness of antibiotics is shrinking. Bacteria is becoming tolerant to antibiotic medication. At Nano-syn, we develop technology that leverages latest scientific advances in nanoparticle synthesis. Enabling pharmaceuticals to win every time against bacteria infections. We are a team of scientists, engineers and business leaders from the United Kingdom and Thailand that have joined together to achieve this vision. With a recent award from The Royal Academy of Engineering, we are combining our expertise in nanoparticle synthesis, computational fluid dynamics and growing enterprises from scientific innovations. We are creating technology advancements and economic growth in these regions of the world. This initiative is led by Dr Amir Keshmiri, Director of CFD Research/CFD Consultancy group based at University of Manchester, UK.
Dr Amir Keshmiri, University of Manchester/Manchester CFD team, United Kingdom. (Read more)
Dr Michael McElroy, Medical Simulation Technologies Limited, United Kingdom. (Read more)
Dr Soracha Thamphiwatana, Prince of Songkla University, Thailand.
Dr Surapong Chatpun, Prince of Songkla University, Thailand.
Mr Nutthaphol Khupsathianwong, Prime Nanotechnology, Thailand.
Dr Moe Roohanifar, Couette Ltd, United Kingdom. (Read more)